Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B
Clinical trial NCT06443645 · RECRUITING
Trial details
- NCT number
- NCT06443645
- Sponsor
- Centre Paul Strauss
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-17
- Primary completion
- 2026-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.